HOLLY HENDERSON: Open Payments
NPI 1710034954 · PALMYRA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 65 payments from 17 companies in 2025. Trend: 2023 $1,210 · 2024 $1,093 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $283 |
| AstraZeneca Pharmaceuticals LP | 9 | $268 |
| Novo Nordisk Inc | 15 | $242 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Axsome Therapeutics, Inc. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $33 |
| PFIZER INC. | 2 | $32 |
Products named: VRAYLAR, AIRSUPRA, Ozempic, Wegovy, REXULTI, CAPLYTA, BREZTRI, Auvelity.
Industry payments across MO — which companies pay providers there.
